|
1）Yatsuga S, Povalko N, Nishioka J, et al. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta-General Subjects. 2012; 1820: 619-24
|
|
|
|
|
2）DiMauro S, Hirano M. MELAS. Gene Reviews [Internet] Last update: Nov. 21, 2013
|
|
|
|
|
|
3）Yasukawa T, Suzuki T, Suzuki T, et al. Modification defect at anticodon wobble nucleotide of mitochondrial tRNAsLeu(UUR) with pathogenic mutations of mitochodrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J Biol Chem. 2000; 275: 4251-7
|
|
|
|
|
4）Yasukawa T, Suzuki T, Ishii N, et al. Defect in modification at the anticodon wobble nucleotide of mitochondrial tRNALys with the MERRF encephalopathy pathogenic mutation. FEBS Lett. 2000; 467: 175-8
|
|
|
|
|
|
5）Suzuki T, Suzuki T, Wada T, et al. Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. EMBO J. 2002; 21: 6581-9
|
|
|
|
|
|
6）Yasukawa T, Suzuki T, Ishii N, et al. Wobble modification defect in tRNA disturbs codon-anticodon interaction in a mitochondrial disease. EMBO J. 2001; 20: 4794-802
|
|
|
|
|
|
7）Torres AG, Batlle E, de Pouplana LR. Role of tRNA modifications in human diseases. Trend Mol Med. 2014; 20: 306-14
|
|
|
|
|
|
8）Suzuki T, Nagao A, Suzuki T. Human mitochondrial diseases caused by lack of taurine modification in mitochondrial tRNAs. WIREs RNA. 2011; 2: 376-86
|
|
|
|
|
|
9）Ito T, Kimura Y, Uozumi Y, et al. Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol. 2008; 44: 927-37
|
|
|
|
|
|
10）Schaffer SW, Jong CJ, Warner D, et al. Taurine deficiency and MELAS are closely related syndromes. Adv Exp Med Biol. 2013; 776: 153-65
|
|
|
|
|
|
11）Rikimaru M, Ohsawa Y, Wolf AM, et al. Taurine ameliorates impaired the mitochondrial function and prevents stroke-like episodes in patients with MELAS. Intern Med. 2012; 51: 3351-7
|
|
|
|
|
12）Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007; 39: 770-5
|
|
|
|
|
|
13）Arragain S, Handelman SK, Forouhar F, et al. Identification of eukaryotic and prokaryotic methylthiotransferase for biosynthesis of 2-methyl-N6-threonylcarbamoyladenosine in tRNA. J Biol Chem. 2010; 285: 28425-33
|
|
|
|
|
|
14）Wei FY, Suzuki T, Watanabe S, et al. Deficit of tRNA (Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice. J Clin Invest. 2011; 121: 3598-608
|
|
|
|
|
|
15）Wei FY, Zhou B, Suzuki T, et al. Cdk5rap1-mediated 2-methylthio modification of mitochondrial tRNAs governs protein translation and con-tributes to myopathy in mice and humans. Cell Metab. 2015; 21: 1-15
|
|
|
|
|